India's common infections are becoming untreatable as widely used antibiotics lose efficacy, according to a new ICMR report.

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria.

When the hospital germ Pseudomonas aeruginosa infects the body, it uses the sugar-binding protein LecA to attach itself to ...

A senior internal medicine specialist explains how everyday illnesses, surgeries, and even cancer care could collapse if ...

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel ...

India faces a growing crisis as common infections become increasingly difficult to treat due to widespread antibiotic ...

Hospitals around the world are bracing for a future where common infections no longer respond to standard drugs. Among the ...

It's an evolutionary battle, an endless competition for survival, that has spanned millions of years. Within this epic tale ...

More than 41,000 bottles of Walgreens-branded nasal spray have been recalled due to potential bacterial contamination.

Much of the current antimicrobial resistance (AMR) crisis in India is driven by overuse of common antibiotics like ...

A hospital-acquired bacterium that causes serious infections can move from the lungs to the gut inside the same patient, ...